Noritsu Koki Co

Noritsu Koki Co Financial Leverage

The Financial Leverage (Equity Multiplier) of Noritsu Koki Co (7744.T) as of Nov 20, 2026 is 1.35. In the previous year, Financial Leverage (Equity Multiplier) was 1.36 — a change of -1.01% (lower).

Financial Leverage

1.35

YoY

-1.01%

Last updated:

Financial Leverage (Equity Multiplier) of Noritsu Koki Co is 2024 1.35 . Financial Leverage (Equity Multiplier) of Noritsu Koki Co was 2023 1.36 . It decreases by -1.01% lower compared to the previous year.

The Noritsu Koki Co Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2017
1.97 JPY
Jan 1, 2018
2.00 JPY
Jan 1, 2019
2.04 JPY
Jan 1, 2020
2.25 JPY
Jan 1, 2021
2.38 JPY
Jan 1, 2022
1.60 JPY
Jan 1, 2023
1.36 JPY
Jan 1, 2024
1.35 JPY
The Noritsu Koki Co Financial Leverage history
YEARFinancial LeverageYoY
1.35-1.01%
1.36-14.73%
1.60-32.93%
2.38+5.97%
2.25+9.92%
2.04+2.24%
2.00+1.42%
1.97-2.98%
2.03+3.75%
1.96-9.44%
2.16—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Noritsu Koki Co Stock analysis

What does Noritsu Koki Co do? Noritsu Koki Co., Ltd. generates revenue through multiple business segments including the Manufacturing segment, which produces pen nib parts and cosmetics materials. The Healthcare segment offers remote diagnostic imaging services and data analysis for healthcare providers. The Drug Discovery segment develops biotechnology products, while the Senior and Life segment manages senior publishing and mail order sales. The Agri-food segment sells fresh vegetables, and the Others segment focuses on new growth investments. The company's products are sold to various clients within each segment, such as healthcare institutions for diagnostic services, biotech firms for drug discovery solutions, and retail customers for senior publishing and fresh vegetables. The Agri-food segment's fresh vegetables are supplied to consumers through direct sales channels. Noritsu Koki's revenue streams are diversified across six distinct segments, with each segment targeting specific market needs. The Manufacturing segment serves industrial clients requiring precision components, while the Healthcare segment caters to medical facilities seeking remote diagnostic support. The Drug Discovery segment partners with biotechnology companies for innovative product development. Noritsu Koki Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Noritsu Koki Co stock

Financial Leverage (Equity Multiplier) of Noritsu Koki Co is 1.35 in 2024.

Financial Leverage (Equity Multiplier) of Noritsu Koki Co changed from 1.36 to 1.35, representing a -1.01% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Noritsu Koki Co since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Noritsu Koki Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Noritsu Koki Co

All Key Metrics — Noritsu Koki Co